Back to Results
First PageMeta Content
Pharmaceuticals policy / Pharmacology / Drug discovery / Orphan drug / Food and Drug Administration / Orphan Drug Act / Rare disease / Xyrem / Prescription Drug User Fee Act / Pharmaceutical sciences / Health / Clinical research


Developing Your Orphan Drug Marlene E. Haffner, M.D., M.P.H. Director, FDA Office of Orphan Products Development
Add to Reading List

Open Document

File Size: 550,26 KB

Share Result on Facebook

Country

United States / /

IndustryTerm

treatment for rare diseases / /

MedicalCondition

MS / Diseases / disorders / /

Organization

office of Orphan Products Development / National Institute of Health / U.S. Food and Drug Administration / U.S. Food & Drug Administration / Federal Government / /

Person

Assistance Webinar Silver Spring / Katherine Needleman / /

Position

Director / /

PublishedMedium

the FDA review / /

SocialTag